Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending February 14, 2003. The report details a specific corporate action regarding share re-purchases executed in accordance with shareholder authority granted at the Annual General Meeting on May 20, 2002.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share re-purchase transaction:
- Shares Purchased: 900,000 Ordinary 25 pence shares.
- Transaction Date: February 13, 2003.
- Price Per Share: 1,106.85 pence.
- Purpose: Purchase for cancellation.
Material Changes
The filing does not report material changes in operating results or financial position compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 900,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, risk factors, or contingencies. It is a procedural announcement of a completed share buyback.
Key Facts for Investor Verification
- Verify the total number of shares authorized for re-purchase under the May 20, 2002 shareholder resolution to determine remaining capacity.
- Confirm the total cash outflow for this specific transaction (900,000 shares x 1,106.85 pence).
- Check subsequent filings for the impact of this cancellation on the company's total share count and earnings per share.